$TLOG Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in TETRALOGIC PHARMACEUTICALS Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in TETRALOGIC PHARMACEUTICALS Corp. Get notifications about new insider transactions in TETRALOGIC PHARMACEUTICALS Corp for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 14 2016 | TLOG | TETRALOGIC PHARMAC ... | WHITEBOX ADVISORS LLC | Option Exercise | J | 0.00 | 3,018,260 | 0 | 3,018,260 | ||
Nov 14 2016 | TLOG | TETRALOGIC PHARMAC ... | NOMURA SECURITIES INTERNATIONA ... | Option Exercise | J | 0.00 | 892,850 | 0 | 892,850 | ||
Nov 14 2016 | TLOG | TETRALOGIC PHARMAC ... | Hudson Bay Capital Management ... | Option Exercise | J | 0.00 | 279,367 | 0 | 279,367 | ||
Nov 14 2016 | TLOG | TETRALOGIC PHARMAC ... | GEODE CAPITAL MANAGEMENT LP | Option Exercise | J | 0.00 | 1,257,144 | 0 | 1,257,144 | ||
Nov 14 2016 | TLOG | TETRALOGIC PHARMAC ... | TELEMETRY SECURITIES, L.L.C. | Option Exercise | J | 0.00 | 838,094 | 0 | 838,094 | ||
Nov 14 2016 | TLOG | TETRALOGIC PHARMAC ... | LINDEN ADVISORS LP | Option Exercise | J | 0.00 | 2,095,239 | 0 | 2,095,239 | ||
Nov 14 2016 | TLOG | TETRALOGIC PHARMAC ... | LAZARD ASSET MANAGEMENT LLC | Option Exercise | J | 0.00 | 1,463,594 | 0 | 1,463,594 | ||
Nov 14 2016 | TLOG | TETRALOGIC PHARMAC ... | State of New Jersey Common Pen ... | Option Exercise | J | 0.00 | 911,011 | 0 | 911,011 | ||
Feb 10 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.16 | 230,507 | 36,881 | 2,214,523 | 2.4 M to 2.2 M (-9.43 %) |
Feb 10 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.19 | 103,123 | 19,593 | 2,445,030 | 2.5 M to 2.4 M (-4.05 %) |
Feb 05 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.20 | 832,881 | 166,576 | 2,548,153 | 3.4 M to 2.5 M (-24.63 %) |
Feb 05 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.14 | 500,026 | 70,004 | 3,381,034 | 3.9 M to 3.4 M (-12.88 %) |
Feb 05 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.15 | 82,583 | 12,387 | 3,881,060 | 4 M to 3.9 M (-2.08 %) |
Feb 02 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.17 | 176,306 | 29,972 | 3,963,643 | 4.1 M to 4 M (-4.26 %) |
Feb 02 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.20 | 140,000 | 28,000 | 4,139,949 | 4.3 M to 4.1 M (-3.27 %) |
Feb 02 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.26 | 52,826 | 13,735 | 4,279,949 | 4.3 M to 4.3 M (-1.22 %) |
Jan 28 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.26 | 32,521 | 8,455 | 4,332,775 | 4.4 M to 4.3 M (-0.74 %) |
Jan 28 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.27 | 209,984 | 56,696 | 4,365,296 | 4.6 M to 4.4 M (-4.59 %) |
Jan 28 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.30 | 69,425 | 20,828 | 4,575,280 | 4.6 M to 4.6 M (-1.49 %) |
Jul 14 2015 | TLOG | TETRALOGIC PHARMAC ... | Pecora Andrew L | Director | Buy | P | 2.79 | 9,200 | 25,668 | 184,830 | 175.6 K to 184.8 K (+5.24 %) |
Jul 14 2015 | TLOG | TETRALOGIC PHARMAC ... | Pecora Andrew L | Director | Buy | P | 2.75 | 800 | 2,200 | 175,630 | 174.8 K to 175.6 K (+0.46 %) |
Jul 14 2015 | TLOG | TETRALOGIC PHARMAC ... | Pecora Andrew L | Director | Buy | P | 2.75 | 7,608 | 20,884 | 174,830 | 167.2 K to 174.8 K (+4.55 %) |
Jul 14 2015 | TLOG | TETRALOGIC PHARMAC ... | Pecora Andrew L | Director | Buy | P | 2.74 | 6,900 | 18,927 | 167,222 | 160.3 K to 167.2 K (+4.30 %) |
Jul 14 2015 | TLOG | TETRALOGIC PHARMAC ... | Pecora Andrew L | Director | Buy | P | 2.74 | 10,000 | 27,370 | 160,322 | 150.3 K to 160.3 K (+6.65 %) |
Jul 14 2015 | TLOG | TETRALOGIC PHARMAC ... | Pecora Andrew L | Director | Buy | P | 2.69 | 2,100 | 5,649 | 150,322 | 148.2 K to 150.3 K (+1.42 %) |
Jul 14 2015 | TLOG | TETRALOGIC PHARMAC ... | Pecora Andrew L | Director | Buy | P | 2.66 | 908 | 2,414 | 148,222 | 147.3 K to 148.2 K (+0.62 %) |
Jul 14 2015 | TLOG | TETRALOGIC PHARMAC ... | Pecora Andrew L | Director | Buy | P | 2.65 | 1,092 | 2,894 | 147,314 | 146.2 K to 147.3 K (+0.75 %) |
Jul 14 2015 | TLOG | TETRALOGIC PHARMAC ... | Pecora Andrew L | Director | Buy | P | 2.57 | 92 | 236 | 146,222 | 146.1 K to 146.2 K (+0.06 %) |
Jul 14 2015 | TLOG | TETRALOGIC PHARMAC ... | Pecora Andrew L | Director | Buy | P | 2.54 | 1,300 | 3,302 | 146,130 | 144.8 K to 146.1 K (+0.90 %) |
Jul 14 2015 | TLOG | TETRALOGIC PHARMAC ... | Pecora Andrew L | Director | Buy | P | 2.44 | 10,000 | 24,400 | 144,830 | 134.8 K to 144.8 K (+7.42 %) |
Jul 13 2015 | TLOG | TETRALOGIC PHARMAC ... | Pecora Andrew L | Director | Buy | P | 2.41 | 10,000 | 24,090 | 134,830 | 124.8 K to 134.8 K (+8.01 %) |
Jul 13 2015 | TLOG | TETRALOGIC PHARMAC ... | Pecora Andrew L | Director | Buy | P | 2.40 | 40,000 | 96,000 | 124,830 | 84.8 K to 124.8 K (+47.15 %) |
Jul 06 2015 | TLOG | TETRALOGIC PHARMAC ... | Schmitt Paul J | Director | Buy | P | 2.34 | 6,500 | 15,188 | 20,000 | 13.5 K to 20 K (+48.15 %) |
Jul 06 2015 | TLOG | TETRALOGIC PHARMAC ... | Schmitt Paul J | Director | Buy | P | 2.33 | 3,500 | 8,169 | 13,500 | 10 K to 13.5 K (+35.00 %) |
Mar 31 2015 | TLOG | TETRALOGIC PHARMAC ... | Meyers Pete A. | CFO & Treasurer | Buy | P | 4.35 | 5,000 | 21,750 | 153,891 | 148.9 K to 153.9 K (+3.36 %) |
Mar 30 2015 | TLOG | TETRALOGIC PHARMAC ... | BUCHI J KEVIN | President & CEO | Buy | P | 4.23 | 5,000 | 21,148 | 330,714 | 325.7 K to 330.7 K (+1.54 %) |
Jan 30 2015 | TLOG | TETRALOGIC PHARMAC ... | Sherman Richard L. | See Remarks | Option Exercise | A | 0.00 | 75,000 | 0 | 0 | |
Jan 30 2015 | TLOG | TETRALOGIC PHARMAC ... | Sherman Richard L. | See Remarks | Option Exercise | A | 5.25 | 100,000 | 525,000 | 424,705 | |
Jan 30 2015 | TLOG | TETRALOGIC PHARMAC ... | Woody James N. | Director | Option Exercise | A | 5.25 | 10,000 | 52,500 | 30,000 | |
Jan 30 2015 | TLOG | TETRALOGIC PHARMAC ... | Schmitt Paul J | Director | Option Exercise | A | 5.25 | 10,000 | 52,500 | 30,000 | |
Jan 30 2015 | TLOG | TETRALOGIC PHARMAC ... | Reed Douglas MD | Director | Option Exercise | A | 5.25 | 10,000 | 52,500 | 30,000 | |
Jan 30 2015 | TLOG | TETRALOGIC PHARMAC ... | STEINMETZ MICHAEL | Director | Option Exercise | A | 5.25 | 10,000 | 52,500 | 30,000 | |
Jan 30 2015 | TLOG | TETRALOGIC PHARMAC ... | KISHBAUCH MICHAEL D | Director | Option Exercise | A | 5.25 | 10,000 | 52,500 | 30,000 | |
Jan 30 2015 | TLOG | TETRALOGIC PHARMAC ... | GRAY MARY ANN | Director | Option Exercise | A | 5.25 | 10,000 | 52,500 | 30,000 | |
Jan 30 2015 | TLOG | TETRALOGIC PHARMAC ... | Russell Lesley | Chief Operating Off ... | Option Exercise | A | 0.00 | 75,000 | 0 | 0 | |
Jan 30 2015 | TLOG | TETRALOGIC PHARMAC ... | Russell Lesley | Chief Operating Off ... | Option Exercise | A | 5.25 | 100,000 | 525,000 | 611,195 | |
Jan 30 2015 | TLOG | TETRALOGIC PHARMAC ... | Meyers Pete A. | CFO & Treasurer | Option Exercise | A | 0.00 | 75,000 | 0 | 0 | |
Jan 30 2015 | TLOG | TETRALOGIC PHARMAC ... | Meyers Pete A. | CFO & Treasurer | Option Exercise | A | 5.25 | 100,000 | 525,000 | 611,195 | |
Jan 30 2015 | TLOG | TETRALOGIC PHARMAC ... | Pecora Andrew L | Director | Option Exercise | A | 5.25 | 10,000 | 52,500 | 77,644 | |
Jan 30 2015 | TLOG | TETRALOGIC PHARMAC ... | BUCHI J KEVIN | President & CEO | Option Exercise | A | 0.00 | 150,000 | 0 | 0 | |
Jan 30 2015 | TLOG | TETRALOGIC PHARMAC ... | BUCHI J KEVIN | President & CEO | Option Exercise | A | 5.25 | 200,000 | 1,050,000 | 1,222,389 | |
Jan 30 2015 | TLOG | TETRALOGIC PHARMAC ... | Begley Colin Glenn | Chief Scientific Of ... | Option Exercise | A | 0.00 | 75,000 | 0 | 0 | |
Jan 30 2015 | TLOG | TETRALOGIC PHARMAC ... | Begley Colin Glenn | Chief Scientific Of ... | Option Exercise | A | 5.25 | 100,000 | 525,000 | 173,705 | |
Jan 29 2015 | TLOG | TETRALOGIC PHARMAC ... | ONSI DOUGLAS E | Director | Option Exercise | A | 5.25 | 10,000 | 52,500 | 10,000 | |
Jan 09 2015 | TLOG | TETRALOGIC PHARMAC ... | BUCHI J KEVIN | President & CEO | Buy | P | 5.04 | 5,000 | 25,181 | 325,714 | 320.7 K to 325.7 K (+1.56 %) |
Dec 12 2014 | TLOG | TETRALOGIC PHARMAC ... | Begley Colin Glenn | Chief Scientific Of ... | Buy | P | 6.16 | 5,900 | 36,344 | 198,134 | 192.2 K to 198.1 K (+3.07 %) |
Dec 11 2014 | TLOG | TETRALOGIC PHARMAC ... | BUCHI J KEVIN | President & CEO | Buy | P | 6.01 | 5,000 | 30,060 | 320,714 | 315.7 K to 320.7 K (+1.58 %) |
Dec 08 2014 | TLOG | TETRALOGIC PHARMAC ... | Meyers Pete A. | CFO & Treasurer | Buy | P | 4.94 | 1,034 | 5,108 | 148,891 | 147.9 K to 148.9 K (+0.70 %) |
Dec 04 2014 | TLOG | TETRALOGIC PHARMAC ... | BUCHI J KEVIN | President & CEO | Buy | P | 4.99 | 10,000 | 49,900 | 315,714 | 305.7 K to 315.7 K (+3.27 %) |
Dec 01 2014 | TLOG | TETRALOGIC PHARMAC ... | Begley Colin Glenn | Chief Scientific Of ... | Buy | P | 4.87 | 1,100 | 5,352 | 1,100 | 0 to 1.1 K |
Dec 01 2014 | TLOG | TETRALOGIC PHARMAC ... | Begley Colin Glenn | Chief Scientific Of ... | Buy | P | 4.90 | 1,000 | 4,900 | 192,234 | 191.2 K to 192.2 K (+0.52 %) |
Dec 01 2014 | TLOG | TETRALOGIC PHARMAC ... | Begley Colin Glenn | Chief Scientific Of ... | Buy | P | 4.81 | 1,000 | 4,810 | 191,234 | 190.2 K to 191.2 K (+0.53 %) |
Dec 01 2014 | TLOG | TETRALOGIC PHARMAC ... | Russell Lesley | Chief Operating Off ... | Buy | P | 4.90 | 20,000 | 97,970 | 20,000 | 0 to 20 K |
Nov 20 2014 | TLOG | TETRALOGIC PHARMAC ... | BUCHI J KEVIN | President & CEO | Buy | P | 4.82 | 10,000 | 48,185 | 305,714 | 295.7 K to 305.7 K (+3.38 %) |
Nov 19 2014 | TLOG | TETRALOGIC PHARMAC ... | Pecora Andrew L | Director | Buy | P | 4.53 | 20,000 | 90,640 | 84,830 | 64.8 K to 84.8 K (+30.85 %) |
Nov 13 2014 | TLOG | TETRALOGIC PHARMAC ... | Meyers Peter A. | CFO & Treasurer | Buy | P | 3.98 | 5,000 | 19,890 | 147,857 | 142.9 K to 147.9 K (+3.50 %) |
Nov 13 2014 | TLOG | TETRALOGIC PHARMAC ... | BUCHI J KEVIN | President and CEO | Buy | P | 3.93 | 10,000 | 39,325 | 295,714 | 285.7 K to 295.7 K (+3.50 %) |
Nov 12 2014 | TLOG | TETRALOGIC PHARMAC ... | Schmitt Paul J | Director | Buy | P | 4.14 | 10,000 | 41,352 | 10,000 | 0 to 10 K |
Nov 12 2014 | TLOG | TETRALOGIC PHARMAC ... | Schmitt Paul J | Director | Buy | P | 4.06 | 10,000 | 40,630 | 10,000 | 0 to 10 K |
Nov 07 2014 | TLOG | TETRALOGIC PHARMAC ... | KISHBAUCH MICHAEL D | Director | Option Exercise | A | 3.87 | 20,000 | 77,400 | 20,000 | |
Nov 07 2014 | TLOG | TETRALOGIC PHARMAC ... | GRAY MARY ANN | Director | Option Exercise | A | 3.87 | 20,000 | 77,400 | 20,000 | |
Jun 09 2014 | TLOG | TETRALOGIC PHARMAC ... | Sherman Richard L. | See Remarks | Option Exercise | A | 6.65 | 100,000 | 665,000 | 324,705 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Woody James N. | Director | Option Exercise | X | 6.40 | 71 | 455 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Woody James N. | Director | Option Exercise | X | 6.40 | 143 | 916 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Woody James N. | Director | Option Exercise | X | 6.40 | 2,850 | 18,246 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Woody James N. | Director | Option Exercise | C | 7.00 | 2,602 | 18,214 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Woody James N. | Director | Option Exercise | C | 7.00 | 5,205 | 36,435 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Woody James N. | Director | Option Exercise | C | 7.00 | 104,118 | 728,826 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Woody James N. | Director | Option Exercise | C | 0.00 | 5,681 | 0 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Woody James N. | Director | Option Exercise | C | 0.00 | 11,363 | 0 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Woody James N. | Director | Option Exercise | C | 0.00 | 227,266 | 0 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Woody James N. | Director | Option Exercise | C | 0.00 | 8,866 | 0 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Woody James N. | Director | Option Exercise | C | 0.00 | 17,733 | 0 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Woody James N. | Director | Option Exercise | C | 0.00 | 354,663 | 0 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Woody James N. | Director | Buy | X | 6.40 | 71 | 455 | 1,001,988 | 1 M to 1 M (+0.01 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Woody James N. | Director | Buy | X | 6.40 | 143 | 916 | 1,001,917 | 1 M to 1 M (+0.01 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Woody James N. | Director | Buy | X | 6.40 | 2,850 | 18,246 | 1,001,774 | 998.9 K to 1 M (+0.29 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Woody James N. | Director | Buy | C | 7.00 | 2,602 | 18,214 | 998,924 | 996.3 K to 998.9 K (+0.26 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Woody James N. | Director | Buy | C | 7.00 | 5,205 | 36,435 | 996,322 | 991.1 K to 996.3 K (+0.53 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Woody James N. | Director | Buy | C | 7.00 | 104,118 | 728,826 | 991,117 | 887 K to 991.1 K (+11.74 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Woody James N. | Director | Buy | C | 0.00 | 5,681 | 0 | 886,999 | 881.3 K to 887 K (+0.64 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Woody James N. | Director | Buy | C | 0.00 | 11,363 | 0 | 881,318 | 870 K to 881.3 K (+1.31 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Woody James N. | Director | Buy | C | 0.00 | 227,266 | 0 | 869,955 | 642.7 K to 870 K (+35.36 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Woody James N. | Director | Buy | C | 0.00 | 8,866 | 0 | 642,689 | 633.8 K to 642.7 K (+1.40 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Woody James N. | Director | Buy | C | 0.00 | 17,733 | 0 | 633,823 | 616.1 K to 633.8 K (+2.88 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Woody James N. | Director | Buy | C | 0.00 | 354,663 | 0 | 616,090 | 261.4 K to 616.1 K (+135.66 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Woody James N. | Director | Buy | P | 7.00 | 6,079 | 42,553 | 261,427 | 255.3 K to 261.4 K (+2.38 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Woody James N. | Director | Buy | P | 7.00 | 12,159 | 85,113 | 255,348 | 243.2 K to 255.3 K (+5.00 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Woody James N. | Director | Buy | P | 7.00 | 243,189 | 1,702,323 | 243,189 | 0 to 243.2 K |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Schmitt Paul J | Director | Option Exercise | X | 6.40 | 5,305 | 33,964 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Schmitt Paul J | Director | Option Exercise | C | 7.00 | 193,863 | 1,357,041 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Schmitt Paul J | Director | Option Exercise | C | 0.00 | 427,440 | 0 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Schmitt Paul J | Director | Option Exercise | C | 0.00 | 179,738 | 0 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Schmitt Paul J | Director | Option Exercise | C | 0.00 | 261,437 | 0 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Schmitt Paul J | Director | Buy | X | 6.40 | 5,305 | 33,964 | 1,512,962 | 1.5 M to 1.5 M (+0.35 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Schmitt Paul J | Director | Buy | C | 7.00 | 193,863 | 1,357,041 | 1,507,657 | 1.3 M to 1.5 M (+14.76 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Schmitt Paul J | Director | Buy | C | 0.00 | 427,440 | 0 | 1,313,794 | 886.4 K to 1.3 M (+48.22 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Schmitt Paul J | Director | Buy | C | 0.00 | 179,738 | 0 | 886,354 | 706.6 K to 886.4 K (+25.44 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Schmitt Paul J | Director | Buy | C | 0.00 | 261,437 | 0 | 706,616 | 445.2 K to 706.6 K (+58.73 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Schmitt Paul J | Director | Buy | P | 7.00 | 445,179 | 3,116,253 | 445,179 | 0 to 445.2 K |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Meyers Peter A. | CFO & Treasurer | Option Exercise | A | 7.00 | 164,394 | 1,150,758 | 487,888 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Meyers Peter A. | CFO & Treasurer | Buy | P | 7.00 | 142,857 | 999,999 | 142,857 | 0 to 142.9 K |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Gavin Brenda D | Director | Option Exercise | C | 7.00 | 48,183 | 337,281 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Gavin Brenda D | Director | Buy | C | 7.00 | 48,183 | 337,281 | 948,268 | 900.1 K to 948.3 K (+5.35 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Russell Lesley | Chief Operating Off ... | Option Exercise | A | 7.00 | 164,394 | 1,150,758 | 487,888 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Pecora Andrew L | Director | Option Exercise | X | 6.40 | 161 | 1,031 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Pecora Andrew L | Director | Option Exercise | C | 7.00 | 5,887 | 41,209 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Pecora Andrew L | Director | Option Exercise | C | 0.00 | 16,055 | 0 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Pecora Andrew L | Director | Buy | X | 6.40 | 161 | 1,031 | 64,830 | 64.7 K to 64.8 K (+0.25 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Pecora Andrew L | Director | Buy | C | 7.00 | 5,887 | 41,209 | 64,669 | 58.8 K to 64.7 K (+10.01 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Pecora Andrew L | Director | Buy | C | 0.00 | 16,055 | 0 | 58,782 | 42.7 K to 58.8 K (+37.58 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Pecora Andrew L | Director | Buy | P | 7.00 | 26,551 | 185,857 | 42,727 | 16.2 K to 42.7 K (+164.14 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | BUCHI J KEVIN | President and CEO | Option Exercise | A | 7.00 | 167,040 | 1,169,280 | 975,775 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | BUCHI J KEVIN | President and CEO | Buy | P | 7.00 | 285,714 | 1,999,998 | 285,714 | 0 to 285.7 K |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | X | 6.40 | 23,282 | 149,056 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | C | 7.00 | 853,416 | 5,973,912 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,342,944 | 0 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | X | 6.40 | 23,282 | 149,056 | 4,644,705 | 4.6 M to 4.6 M (+0.50 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | C | 7.00 | 853,416 | 5,973,912 | 4,621,423 | 3.8 M to 4.6 M (+22.65 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | C | 0.00 | 2,342,944 | 0 | 3,768,007 | 1.4 M to 3.8 M (+164.41 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | P | 7.00 | 1,425,063 | 9,975,441 | 1,425,063 | 0 to 1.4 M |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Reed Douglas MD | Director | Option Exercise | X | 6.40 | 7,590 | 48,593 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Reed Douglas MD | Director | Option Exercise | C | 7.00 | 278,315 | 1,948,205 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Reed Douglas MD | Director | Option Exercise | C | 0.00 | 780,980 | 0 | 0 | |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Reed Douglas MD | Director | Buy | X | 6.40 | 7,590 | 48,593 | 1,209,742 | 1.2 M to 1.2 M (+0.63 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Reed Douglas MD | Director | Buy | C | 7.00 | 278,315 | 1,948,205 | 1,202,152 | 923.8 K to 1.2 M (+30.13 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Reed Douglas MD | Director | Buy | C | 0.00 | 780,980 | 0 | 923,837 | 142.9 K to 923.8 K (+546.69 %) |
Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Reed Douglas MD | Director | Buy | P | 7.00 | 142,857 | 999,999 | 142,857 | 0 to 142.9 K |
Dec 18 2013 | TLOG | TETRALOGIC PHARMAC ... | AMGEN INC | 10% Owner | Option Exercise | X | 6.40 | 13,355 | 85,501 | 0 | |
Dec 18 2013 | TLOG | TETRALOGIC PHARMAC ... | AMGEN INC | 10% Owner | Option Exercise | C | 0.00 | 117,361 | 0 | 0 | |
Dec 18 2013 | TLOG | TETRALOGIC PHARMAC ... | AMGEN INC | 10% Owner | Option Exercise | C | 0.00 | 108,932 | 0 | 0 | |
Dec 18 2013 | TLOG | TETRALOGIC PHARMAC ... | AMGEN INC | 10% Owner | Buy | P | 7.00 | 272,142 | 1,904,994 | 541,399 | 269.3 K to 541.4 K (+101.07 %) |
Dec 18 2013 | TLOG | TETRALOGIC PHARMAC ... | AMGEN INC | 10% Owner | Buy | X | 6.40 | 1,141 | 7,305 | 269,257 | 268.1 K to 269.3 K (+0.43 %) |
Dec 18 2013 | TLOG | TETRALOGIC PHARMAC ... | AMGEN INC | 10% Owner | Buy | C | 0.00 | 268,116 | 0 | 268,116 | 0 to 268.1 K |
Dec 18 2013 | TLOG | TETRALOGIC PHARMAC ... | AMGEN INC | 10% Owner | Buy | C | 0.00 | 448,767 | 0 | 448,767 | 0 to 448.8 K |
Dec 17 2013 | TLOG | TETRALOGIC PHARMAC ... | HEALTHCARE VENTURES VII LP | 10% Owner | Option Exercise | C | 0.00 | 8,603,477 | 0 | 0 | |
Dec 17 2013 | TLOG | TETRALOGIC PHARMAC ... | HEALTHCARE VENTURES VII LP | 10% Owner | Option Exercise | C | 0.00 | 7,453,704 | 0 | 0 | |
Dec 17 2013 | TLOG | TETRALOGIC PHARMAC ... | HEALTHCARE VENTURES VII LP | 10% Owner | Option Exercise | C | 0.00 | 5,000,000 | 0 | 0 | |
Dec 17 2013 | TLOG | TETRALOGIC PHARMAC ... | HEALTHCARE VENTURES VII LP | 10% Owner | Buy | P | 7.00 | 713,463 | 4,994,241 | 2,586,466 | 1.9 M to 2.6 M (+38.09 %) |
Dec 17 2013 | TLOG | TETRALOGIC PHARMAC ... | HEALTHCARE VENTURES VII LP | 10% Owner | Buy | C | 7.00 | 267,535 | 1,872,745 | 1,873,003 | 1.6 M to 1.9 M (+16.66 %) |